Nottingham Respiratory Research Unit

Nottingham Respiratory Research Unit The Nottingham Respiratory Research Unit conducts world leading research into respiratory conditions

We are one of the leading respiratory research units in the UK and the Respiratory Theme the National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre. Our organisation is a collaboration between Nottingham University Hospitals NHS Trust and the University of Nottingham. In addition, we are very grateful for the support overtime from Nottingham Hospitals Charity. Our funders give us the support to facilitate the translational respiratory research. Our team consists of both academic and clinical researchers. Highly skilled and experienced nurses and administrative staff make up an exceptional team. We have close links on respiratory themes with researchers within other research groupings in Nottingham such as epidemiology, molecular microbiology, drug discovery, allergy, immunology and child health. We are also part of several major national/international collaborations (eg MRCMAP COPD, NIHR TRP in inflammatory diseases and UBIOPRED IMI consortia working closely with industry and major academic institutions and also host the National Centre for research into lymphangiolyomyomatosis (LAM). WHAT DO WE DO

The NRRU is dedicated to delivering high quality, patient-centred research, in order to advance knowledge and improve health outcomes for people with respiratory conditions such as Asthma, COPD and IPF. By Integrating research with clinical care has established us as one of the leading respiratory research units in the UK, with a proven track record of successful participant recruitment and positive participant experience. We achieve this by:
Active and meaningful patient and public involvement and engagement in our research to ensure they are at the heart of everything we do. Performing specialised tests in our state of the art facilities. Providing a safe environment with a highly skilled, professional team. Maintaining and expanding our extensive research volunteer database. Continuing international collaborations with leading researchers in the respiratory field.

We have recently commenced a new study sponsored by Avalyn Pharma and led at Nottingham University Hospitals by Dr Sy Gi...
19/07/2025

We have recently commenced a new study sponsored by Avalyn Pharma and led at Nottingham University Hospitals by Dr Sy Giin Chong.

New Placebo-Controlled Study of Inhaled Pirfenidone in Progressive Pulmonary Fibrosis.

The Sponsor is developing AP01 (also referred to in this document as the “study drug”) for use in the treatment of Progressive Pulmonary Fibrosis. AP01 is an experimental drug that may slow your PPF symptoms. You will inhale the study drug using the eFlow Nebuliser System.

Address

Clinical Sciences Building, NUH City Hospital, Hucknall Road
Nottingham
NG51PB

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Telephone

+441158404844

Website

http://www.nuh.nhs.uk/research

Alerts

Be the first to know and let us send you an email when Nottingham Respiratory Research Unit posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category